Clinical Case Reports (Nov 2022)
Euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus 3 days after initiating sodium‐glucose cotransporter 2 inhibitor while on an extremely low carbohydrate diet: A case report
Abstract
Abstract This paper presents a case with type 2 diabetes mellitus on a very‐low‐carbohydrate diet who developed euglycemic diabetic ketoacidosis (EDKA) 3 days after starting sodium‐glucose cotransporter 2 inhibitors (SGLT2i). When initiating SGLT2i, healthcare providers should confirm the implementation of a low‐carbohydrate diet and provide intensive guidance to prevent EDKA.
Keywords